+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Biologics Global Market Report 2020-30: COVID-19 Impact and Recovery

  • ID: 5028647
  • Report
  • May 2020
  • Region: Global
  • 400 pages
  • The Business Research Company
1 of 5

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • AbbVie
  • Bristol-Myers Squibb
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline Plc.
  • Johnson & Johnson
  • MORE
Biologics Global Market Report 2020-30: COVID-19 Impact and Recovery from the publisher provides the strategists, marketers and senior management with the critical information they need to assess the global biologics market as it emerges from the COVID-19 shut down.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3 working days of order.
Description:
Where is the largest and fastest growing market for the biologics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Biologics market global report from the publisher answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider biologics market, and compares it with other markets.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the COVID-19 virus and forecasting its recovery.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The biologics market section of the report gives context. It compares the biologics market with other segments of the pharmaceuticals market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, biologics indicators comparison.
Scope

Markets Covered:
1) By Type: Monoclonal Antibodies (MAbS); Therapeutic Proteins; Vaccines
2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/ Drug Stores; Others
3) By Route Of Administration: Oral; Parenteral; Others
4) By Drug Classification: Branded Drugs; Generic Drugs
5) By Mode Of Purchase: Prescription-Based Drugs; Over-The-Counter Drugs

Subsegments Covered: Anti-Cancer MAbS; Immunological MAbS; Anti-Infective Monoclonal Antibodies (MAbs); Neuropharmacological MABS; Cardiovascular And Cerebrovascular MAbS; Others - Monoclonal Antibodies (MAbs); Metabolic Disorders Therapeutic Proteins; Cancer Therapeutic Proteins; Cardiovascular Therapeutic Proteins; Immunological Therapeutic Proteins; Others - Therapeutic Proteins; Anti-Infective Vaccines; Autoimmunity Vaccines; Others-Vaccines

Companies Mentioned: Johnson & Johnson; F. Hoffmann-La Roche Ltd.; Bristol-Myers Squibb; GlaxoSmithKline Plc.; AbbVie

Metrics Covered: Number of Enterprises; Number of Employees

Countries: Argentina; Australia; Austria; Belgium; Brazil; Canada; Chile; China; Colombia; Czech Republic; Denmark; Egypt; Finland; France; Germany; Hong Kong; India; Indonesia; Ireland; Israel; Italy; Japan; Malaysia; Mexico; Netherlands; New Zealand; Nigeria; Norway; Peru; Philippines; Poland; Portugal; Romania; Russia; Saudi Arabia; Singapore; South Africa; South Korea; Spain; Sweden; Switzerland; Thailand; Turkey; UAE; UK; USA; Venezuela; Vietnam

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita, biologics indicators comparison.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

This report will be delivered within 1-3 business days.
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • AbbVie
  • Bristol-Myers Squibb
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline Plc.
  • Johnson & Johnson
  • MORE
1. Executive Summary

2. Report Structure

3. Biologics Market Characteristics
3.1. Market Definition
3.2. Key Segmentations

4. Biologics Market Product Analysis
4.1. Leading Products/ Services
4.2. Key Features and Differentiators
4.3. Development Products

5. Biologics Market Supply Chain
5.1. Supply Chain
5.2. Distribution
5.3. End Customers

6. Biologics Market Customer Information
6.1. Customer Preferences
6.2. End Use Market Size and Growth

7. Biologics Market Trends And Strategies

8. Biologics Market Size And Growth
8.1. Market Size
8.2. Historic Market Growth, Value ($ Billion)
8.2.1. Drivers Of The Market
8.2.2. Restraints On The Market
8.3. Forecast Market Growth, Value ($ Billion)
8.3.1. Drivers Of The Market
8.3.2. Restraints On The Market

9. Biologics Market Regional Analysis
9.1. Global Biologics Market, 2019, By Region, Value ($ Billion)
9.2. Global Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Region
9.3. Global Biologics Market, Growth And Market Share Comparison, By Region

10. Biologics Market Segmentation
10.1. Global Biologics Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Monoclonal Antibodies (MAbS)
  • Therapeutic Proteins
  • Vaccines
10.2. Global Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Hospital Pharmacies
  • Retail Pharmacies/ Drug Stores
  • Others
10.3. Global Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Oral
  • Parenteral
  • Others
10.4. Global Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Branded Drugs
  • Generic Drugs
10.5. Global Biologics Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Prescription-Based Drugs
  • Over-The-Counter Drugs
11. Biologics Market Segments
11.1. Global Monoclonal Antibodies (MAbS) Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion) - Anti-Cancer MAbS; Immunological MAbS; Anti-Infective Monoclonal Antibodies (MAbs); Neuropharmacological MABS; Cardiovascular And Cerebrovascular MAbS; Others - Monoclonal Antibodies (MAbs)
11.2. Global Therapeutic Proteins Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion) - Metabolic Disorders Therapeutic Proteins; Cancer Therapeutic Proteins; Cardiovascular Therapeutic Proteins; Immunological Therapeutic Proteins; Others - Therapeutic Proteins
11.3. Global Vaccines Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion) - Anti-Infective Vaccines; Autoimmunity Vaccines; Others-Vaccines

12. Biologics Market Metrics
12.1. Biologics Market Size, Percentage Of GDP, 2015-2023, Global
12.2. Per Capita Average Biologics Market Expenditure, 2015-2023, Global

13. Asia-Pacific Biologics Market
13.1. Asia-Pacific Biologics Market Overview
13.2. Asia-Pacific, Biologics Market, 2019, By Country, Value ($ Billion)
13.3. Asia-Pacific, Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
13.4. Asia-Pacific, Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
13.5. Asia-Pacific, Biologics Market Metrics
13.5.1. Per Capita Average Biologics Expenditure, 2015-2023, Asia-Pacific Countries
13.5.2. Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2019, Asia-Pacific Countries
13.5.3. Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2019, Asia-Pacific Countries
13.6. Asia-Pacific Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7. Asia-Pacific Biologics Market: Country Analysis
13.7.1. China Biologics Market
13.7.1.1. China Biologics Market Overview
13.7.1.2. China Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.1.3. China Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.2. Australia Biologics Market
13.7.2.1. Australia Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.2.2. Australia Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.3. Hong Kong Biologics Market
13.7.3.1. Hong Kong Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.4. India Biologics Market
13.7.4.1. India Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.4.2. India Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.5. Indonesia Biologics Market
13.7.5.1. Indonesia Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.5.2. Indonesia Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.6. Japan Biologics Market
13.7.6.1. Japan Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.6.2. Japan Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.7. Malaysia Biologics Market
13.7.7.1. Malaysia Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.8. New Zealand Biologics Market
13.7.8.1. New Zealand Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.9. Philippines Biologics Market
13.7.9.1. Philippines Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.10. Singapore Biologics Market
13.7.10.1. Singapore Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.11. South Korea Biologics Market
13.7.11.1. South Korea Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.11.2. South Korea Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.12. Thailand Biologics Market
13.7.12.1. Thailand Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.13. Vietnam Biologics Market
13.7.13.1. Vietnam Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

14. Western Europe Biologics Market
14.1. Western Europe Biologics Market Overview
14.2. Western Europe, Biologics Market, 2019, By Country, Value ($ Billion)
14.3. Western Europe, Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
14.4. Western Europe, Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
14.5. Western Europe, Biologics Market Metrics
14.5.1. Per Capita Average Biologics Expenditure, 2015-2023, Western Europe Countries
14.5.2. Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2019, Western Europe Countries
14.5.3. Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2019, Western Europe Countries
14.6. Western Europe Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
14.7. Western Europe Biologics Market: Country Analysis
14.7.1. Austria Biologics Market
14.7.1.1. Austria Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
14.7.2. Belgium Biologics Market
14.7.2.1. Belgium Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
14.7.3. Denmark Biologics Market
14.7.3.1. Denmark Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
14.7.4. Finland Biologics Market
14.7.4.1. Finland Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
14.7.5. France Biologics Market
14.7.5.1. France Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
14.7.5.2. France Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
14.7.6. Germany Biologics Market
14.7.6.1. Germany Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
14.7.6.2. Germany Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
14.7.7. Ireland Biologics Market
14.7.7.1. Ireland Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
14.7.8. Italy Biologics Market
14.7.8.1. Italy Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
14.7.9. Netherlands Biologics Market
14.7.9.1. Netherlands Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
14.7.10. Norway Biologics Market
14.7.10.1. Norway Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
14.7.11. Portugal Biologics Market
14.7.11.1. Portugal Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
14.7.12. Spain Biologics Market
14.7.12.1. Spain Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
14.7.13. Sweden Biologics Market
14.7.13.1. Sweden Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
14.7.14. Switzerland Biologics Market
14.7.14.1. Switzerland Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
14.7.15. UK Biologics Market
14.7.15.1. UK Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
14.7.15.2. UK Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

15. Eastern Europe Biologics Market
15.1. Eastern Europe Biologics Market Overview
15.2. Eastern Europe, Biologics Market, 2019, By Country, Value ($ Billion)
15.3. Eastern Europe, Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
15.4. Eastern Europe, Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
15.5. Eastern Europe, Biologics Market Metrics
15.5.1. Per Capita Average Biologics Expenditure, 2015-2023, Eastern Europe Countries
15.5.2. Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2019, Eastern Europe Countries
15.5.3. Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2019, Eastern Europe Countries
15.6. Eastern Europe Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
15.7. Eastern Europe Biologics Market: Country Analysis
15.7.1. Czech Republic Biologics Market,
15.7.1.1. Czech Republic Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
15.7.2. Poland Biologics Market
15.7.2.1. Poland Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
15.7.3. Romania Biologics Market
15.7.3.1. Romania Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
15.7.4. Russia Biologics Market
15.7.4.1. Russia Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
15.7.4.2. Russia Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

16. North America Biologics Market
16.1. North America Biologics Market Overview
16.2. North America, Biologics Market, 2019, By Country, Value ($ Billion)
16.3. North America, Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
16.4. North America, Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
16.5. North America, Biologics Market Metrics
16.5.1. Per Capita Average Biologics Expenditure, 2015-2023, North America Countries
16.5.2. Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2019, North America Countries
16.5.3. Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2019, North America Countries
16.6. North America Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
16.7. North America Biologics Market: Country Analysis
16.7.1. Canada Biologics Market
16.7.1.1. Canada Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
16.7.2. Mexico Biologics Market
16.7.2.1. Mexico Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
16.7.3. USA Biologics Market
16.7.3.1. USA Biologics Market Overview
16.7.3.2. USA Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
16.7.3.3. USA Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

17. South America Biologics Market
17.1. South America Biologics Market Overview
17.2. South America, Biologics Market, 2019, By Country, Value ($ Billion)
17.3. South America, Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
17.4. South America, Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
17.5. South America, Biologics Market Metrics
17.5.1. Per Capita Average Biologics Expenditure, 2015-2023, South America Countries
17.5.2. Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2019, South America Countries
17.5.3. Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2019, South America Countries
17.6. South America Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
17.7. South America Biologics Market: Country Analysis
17.7.1. Argentina Biologics Market
17.7.1.1. Argentina Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
17.7.2. Brazil Biologics Market
17.7.1.1. Brazil Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
17.7.2.2. Brazil Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
17.7.3. Chile Biologics Market
17.7.3.1. Chile Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
17.7.4. Colombia Biologics Market
17.7.4.1. Colombia Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
17.7.5. Peru Biologics Market
17.7.5.1. Peru Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
17.7.6. Venezuela Biologics Market
17.7.6.1. Venezuela Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

18. Middle East Biologics Market
18.1. Middle East Biologics Market Overview
18.2. Middle East, Biologics Market, 2019, By Country, Value ($ Billion)
18.3. Middle East, Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
18.4. Middle East, Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
18.5. Middle East, Biologics Market Metrics
18.5.1. Per Capita Average Biologics Expenditure, 2015-2023, Middle East Countries
18.5.2. Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2019, Middle East Countries
18.5.3. Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2019, Middle East Countries
18.6. Middle East Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
18.7. Middle East Biologics Market: Country Analysis
18.7.1. Saudi Arabia Biologics Market
18.7.1.1. Saudi Arabia Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
18.7.2. Israel Biologics Market
18.7.2.1. Israel Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
18.7.3. Turkey Biologics Market
18.7.3.1. Turkey Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
18.7.4. UAE Biologics Market
18.7.4.1. UAE Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

19. Africa Biologics Market
19.1. Africa Biologics Market Overview
19.2. Africa, Biologics Market, 2019, By Country, Value ($ Billion)
19.3. Africa, Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
19.4. Africa, Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
19.5. Africa, Biologics Market Metrics
19.5.1. Per Capita Average Biologics Expenditure, 2015-2023, Africa Countries
19.5.2. Number of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2019, Africa Countries
19.5.3. Number of Employees, Biologics Market, Biologics Market/Number of Employees, 2019, Africa Countries
19.6. Africa Biologics Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
19.7. Africa Biologics Market: Country Analysis
19.7.1. Egypt Biologics Market
19.7.1.1. Egypt Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
19.7.2. Nigeria Biologics Market
19.7.2.1. Nigeria Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
19.7.3. South Africa Biologics Market
19.7.3.1. South Africa Biologics Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

20. Biologics Market Competitive Landscape
20.1. Competitive Market Overview
20.2. Market Shares
20.3. Company Profiles
20.3.1. Johnson & Johnson
20.3.1.1. Company Overview
20.3.1.2. Products And Services
20.3.1.3. Strategy
20.3.1.4. Financial Performance
20.3.2. F. Hoffmann-La Roche Ltd.
20.3.2.1. Company Overview
20.3.2.2. Products And Services
20.3.2.3. Strategy
20.3.2.4. Financial Performance
20.3.3. Bristol-Myers Squibb
20.3.3.1. Company Overview
20.3.3.2. Products And Services
20.3.3.3. Strategy
20.3.3.4. Financial Performance
20.3.4. GlaxoSmithKline Plc.
20.3.4.1. Company Overview
20.3.4.2. Products And Services
20.3.4.3. Strategy
20.3.4.4. Financial Performance
20.3.5. AbbVie
20.3.5.1. Company Overview
20.3.5.2. Products And Services
20.3.5.3. Strategy
20.3.5.4. Financial Performance

21. Key Mergers And Acquisitions In The Biologics Market

22. Market Background: Pharmaceuticals Market
22.1. Pharmaceuticals Market Characteristics
22.2. Pharmaceuticals Market Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F Growth, By Segment, Value ($ Billion), Global
22.3. Global Pharmaceuticals Market, 2019, By Region, Value ($ Billion)
22.4. Global Pharmaceuticals Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Region
22.5. Global Pharmaceuticals Market, 2015-2019, 2023F, 2025F, 2030F, Segmentation By Type, Value ($ Billion)

23. Recommendations
23.1. Global Biologics Market In 2023- Growth Countries
23.2. Global Biologics Market In 2023- Growth Segments
23.3. Global Biologics Market In 2023- Growth Strategies

24. Appendix
24.1. NAICS Definitions Of Industry Covered In This Report
24.2. Abbreviations
24.3. Currencies
24.4. Research Inquiries
24.5. About the Publisher

25. Copyright And Disclaimer
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • AbbVie
  • Bristol-Myers Squibb
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline Plc.
  • Johnson & Johnson
  • MORE
North America was the largest region in the global biologics market, accounting for 53% of the market in 2019. Asia Pacific was the second largest region accounting for 21% of the global biologics market. Africa was the smallest region in the global biologics market.

Biologics are being widely used to provide effective treatment for many complex diseases such as rheumatoid arthritis, psoriasis, Crohn’s disease that have limited treatment options. There has been a significant advance in the treatment of rheumatoid arthritis patients who do not respond to traditional disease-modifying anti-rheumatic drugs. The key biologics used for the treatment of rheumatoid arthritis include Abatacept (Orencia), Adalimumab (Humira), Anakinra (Kineret), Infliximab (Remicade), and Rituximab (Rituxan). Key biologics used to treat psoriasis include Adalimumab (Humira), Etanercept (Enbrel), Infliximab (Remicade), Secukinumab ( Cosentyx). Cimzia (certolizumab pegol), Humira (adalimumab), and Remicade (infliximab), Tysabri (natalizumab) are biologics that are used to treat Crohn’s disease.

The biologics market consists of sales of biologics and related services by entities (organizations, sole traders and partnerships) that produce biologics to treat and prevent various microbial diseases and cancers. This industry includes establishments that produce products that are composed of sugars, proteins, nucleic acids, and combination of all these substances isolated from humans, animal and microorganisms or produced from biotechnology methods.

The global biologics market is expected to decline from $269.2 billion in 2019 to $239.2 billion in 2020 at a compound annual growth rate (CAGR) of -11.2%. The decline is mainly due to the worldwide supply and demand failures of drugs due to the COVID-19 outbreak. The biologic drug shortages because of an inadequate production of biologics is hampering the market growth. The inadequate or slowed production is due to the restrictions imposed by governments of various countries to shutdown factories or function with minimal staffing to contain the spread of virus and keep the staff safe. The market is then expected to recover and grow at a CAGR of 15% from 2021 and reach $464.7 billion in 2023.
Note: Product cover images may vary from those shown
5 of 5
  • Johnson & Johnson
  • F. Hoffmann-La Roche Ltd.
  • Bristol-Myers Squibb
  • GlaxoSmithKline Plc.
  • AbbVie
Note: Product cover images may vary from those shown
6 of 5

Loading
LOADING...

Adroll
adroll